NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

flip, you caught my attention with that headline. The pharmaceutical cold-chain logistics business is an area I’m invested in, so the potential Covid-19 vaccines are of interest. Unfortunately, I doubt that Cognate or the cryogenic storage at Sawston will get any of the covid-19 vaccine business. In the past five years, there has been many partnerships and consolidation in the pharmaceutical distribution and cold-chain logistics business segment, and the new Covid-19 vaccine business will be handled by these major companies.

As a side note to investors praying for a buyout of NWBO: be careful what you wish for. That cryogenic logistics company, Cryoport (CYRX) may have some similarities to Northwest Bio because it had many long-time investors who were forced to endure declining stock prices and reverse stock splits over the years, and who were praying for a miracle buyout at $20 a share. Well that little company went from about $2 in 2017 to $60 last month!

Here’s a couple articles about Covid-19 vaccines cold-chain logistics if interested:

Logistics providers are getting ready for a Covid-19 vaccine surge
September 14, 2020

https://pharmaceuticalcommerce.com/cold-chain-focus/logistics-providers-are-getting-ready-for-a-covid-19-vaccine-surge/

Today’s pharma cold chain is going cryogenic
September 25, 2020 | Updated: September 29, 2020

https://pharmaceuticalcommerce.com/cold-chain-focus/todays-pharma-cold-chain-is-going-cryogenic/